MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential

por Petrek, Hannah, Yu, Ai‐Ming
Publicado 2019

MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells

por Yi, Colleen, Yu, Ai-Ming
Publicado 2022

Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research

por Cronin, Joseph M., Yu, Ai-Ming
Publicado 2023

Advanced knowledge in drug metabolism and pharmacokinetics

por Yu, Ai-Ming, Zhong, Xiao-bo
Publicado 2016

Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination

por Yu, Ai-Ming, Tu, Mei-Juan
Publicado 2022

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies

por Traber, Gavin M., Yu, Ai-Ming
Publicado 2023

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

por Yu, Ai-Ming, Choi, Young Hee, Tu, Mei-Juan
Publicado 2020

Editorial: Post-transcriptional regulation and its misregulation: From molecular basis to translational medicine

por Tian, Ye, Yu, Ai-Ming, Yin, Chong, Qian, Airong
Publicado 2022

Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability

por Jilek, Joseph L., Tu, Mei-Juan, Zhang, Chao, Yu, Ai-Ming
Publicado 2020

A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications

por Chen, Qiu-Xia, Wang, Wei-Peng, Zeng, Su, Urayama, Shiro, Yu, Ai-Ming
Publicado 2015

The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19)

por Batra, Neelu, De Souza, Cristabelle, Batra, Jyoti, Raetz, Alan G., Yu, Ai-Ming
Publicado 2020

Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice

por Jiang, Xi-Ling, Shen, Hong-Wu, Mager, Donald E., Schmidt, Stephan, Yu, Ai-Ming
Publicado 2016

Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions

por Yi, Wan-Rong, Tu, Mei-Juan, Yu, Ai-Xi, Lin, Jun, Yu, Ai-Ming
Publicado 2022

Author correction to ‘Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo’...

por Deng, Linglong, Petrek, Hannah, Tu, Mei-Juan, Batra, Neelu, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2023

MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis

por Tu, Mei-Juan, Pan, Yu-Zhuo, Qiu, Jing-Xin, Kim, Edward J., Yu, Ai-Ming
Publicado 2016

Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression

por Li, Xin, Tian, Ye, Tu, Mei-Juan, Ho, Pui Yan, Batra, Neelu, Yu, Ai-Ming
Publicado 2019

Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo

por Deng, Linglong, Petrek, Hannah, Tu, Mei-Juan, Batra, Neelu, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2021

A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma

por Alegre, Fernando, Ormonde, Amanda R., Snider, Kellie M., Woolard, Kevin, Yu, Ai-Ming, Wittenburg, Luke A.
Publicado 2018

A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism

por Choi, Young Hee, Zhang, Chao, Liu, Zhenzhen, Tu, Mei-Juan, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2021

Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest

por Zhao, Yong, Tu, Mei-Juan, Wang, Wei-Peng, Qiu, Jing-Xin, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2016